nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—SLC6A3—bipolar disorder	0.739	1	CbGaD
Dextroamphetamine—SLC6A2—locus ceruleus—bipolar disorder	0.0151	0.179	CbGeAlD
Dextroamphetamine—SLC18A2—telencephalic ventricle—bipolar disorder	0.0117	0.139	CbGeAlD
Dextroamphetamine—SLC6A3—telencephalic ventricle—bipolar disorder	0.00888	0.105	CbGeAlD
Dextroamphetamine—SLC6A2—autonomic nervous system—bipolar disorder	0.00803	0.0953	CbGeAlD
Dextroamphetamine—TAAR1—thyroid gland—bipolar disorder	0.00582	0.0691	CbGeAlD
Dextroamphetamine—SLC18A2—blood plasma—bipolar disorder	0.0056	0.0664	CbGeAlD
Dextroamphetamine—TAAR1—nervous system—bipolar disorder	0.0049	0.0582	CbGeAlD
Dextroamphetamine—CYP2D6—urine—bipolar disorder	0.00358	0.0425	CbGeAlD
Dextroamphetamine—SLC18A2—thyroid gland—bipolar disorder	0.00198	0.0235	CbGeAlD
Dextroamphetamine—CYP2D6—blood plasma—bipolar disorder	0.00187	0.0222	CbGeAlD
Dextroamphetamine—ADRA1B—nervous system—bipolar disorder	0.00168	0.02	CbGeAlD
Dextroamphetamine—SLC18A2—nervous system—bipolar disorder	0.00166	0.0198	CbGeAlD
Dextroamphetamine—SLC18A2—cerebellum—bipolar disorder	0.00157	0.0186	CbGeAlD
Dextroamphetamine—ADRA1B—brain—bipolar disorder	0.00128	0.0153	CbGeAlD
Dextroamphetamine—SLC18A2—brain—bipolar disorder	0.00127	0.0151	CbGeAlD
Dextroamphetamine—SLC6A3—nervous system—bipolar disorder	0.00126	0.0149	CbGeAlD
Dextroamphetamine—SLC6A3—cerebellum—bipolar disorder	0.00118	0.0141	CbGeAlD
Dextroamphetamine—SLC6A2—nervous system—bipolar disorder	0.00102	0.0121	CbGeAlD
Dextroamphetamine—SLC6A3—brain—bipolar disorder	0.000962	0.0114	CbGeAlD
Dextroamphetamine—ADRA1A—nervous system—bipolar disorder	0.000944	0.0112	CbGeAlD
Dextroamphetamine—ADRA1A—cerebellum—bipolar disorder	0.000889	0.0105	CbGeAlD
Dextroamphetamine—Pargyline—MAOA—bipolar disorder	0.00079	0.0925	CrCbGaD
Dextroamphetamine—SLC6A2—brain—bipolar disorder	0.000776	0.00922	CbGeAlD
Dextroamphetamine—Diethylpropion—SLC6A3—bipolar disorder	0.000776	0.0908	CrCbGaD
Dextroamphetamine—ADRA1A—brain—bipolar disorder	0.000722	0.00857	CbGeAlD
Dextroamphetamine—Lisdexamfetamine—SLC6A3—bipolar disorder	0.000588	0.0688	CrCbGaD
Dextroamphetamine—CYP2D6—nervous system—bipolar disorder	0.000556	0.0066	CbGeAlD
Dextroamphetamine—CYP2D6—cerebellum—bipolar disorder	0.000523	0.00621	CbGeAlD
Dextroamphetamine—Tranylcypromine—MAOA—bipolar disorder	0.000509	0.0596	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—MAOA—bipolar disorder	0.000479	0.056	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—DRD1—bipolar disorder	0.000435	0.051	CrCbGaD
Dextroamphetamine—Phentermine—MAOA—bipolar disorder	0.000427	0.0499	CrCbGaD
Dextroamphetamine—CYP2D6—brain—bipolar disorder	0.000425	0.00505	CbGeAlD
Dextroamphetamine—Phenylpropanolamine—SLC6A3—bipolar disorder	0.000413	0.0483	CrCbGaD
Dextroamphetamine—Pseudoephedrine—MAOA—bipolar disorder	0.000404	0.0473	CrCbGaD
Dextroamphetamine—Selegiline—MAOA—bipolar disorder	0.000395	0.0462	CrCbGaD
Dextroamphetamine—Phentermine—SLC6A3—bipolar disorder	0.000368	0.0431	CrCbGaD
Dextroamphetamine—Pseudoephedrine—SLC6A3—bipolar disorder	0.000349	0.0408	CrCbGaD
Dextroamphetamine—Phenelzine—MAOA—bipolar disorder	0.000348	0.0407	CrCbGaD
Dextroamphetamine—Methamphetamine—MAOA—bipolar disorder	0.000304	0.0356	CrCbGaD
Dextroamphetamine—Amphetamine—SLC6A3—bipolar disorder	0.000283	0.0331	CrCbGaD
Dextroamphetamine—Phentermine—SLC6A4—bipolar disorder	0.000275	0.0322	CrCbGaD
Dextroamphetamine—Methamphetamine—SLC6A3—bipolar disorder	0.000262	0.0307	CrCbGaD
Dextroamphetamine—Pseudoephedrine—SLC6A4—bipolar disorder	0.000261	0.0305	CrCbGaD
Dextroamphetamine—Benzphetamine—SLC6A3—bipolar disorder	0.00026	0.0304	CrCbGaD
Dextroamphetamine—Amphetamine—SLC6A4—bipolar disorder	0.000212	0.0248	CrCbGaD
Dextroamphetamine—Amphetamine—DRD2—bipolar disorder	0.00021	0.0246	CrCbGaD
Dextroamphetamine—Methamphetamine—SLC6A4—bipolar disorder	0.000196	0.0229	CrCbGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000131	0.000779	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000131	0.000779	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TSHB—bipolar disorder	0.000128	0.000762	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PDE4B—bipolar disorder	0.000128	0.000762	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TACR1—bipolar disorder	0.000128	0.000762	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—GRIN2B—bipolar disorder	0.000128	0.00076	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000127	0.000754	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—ADCY2—bipolar disorder	0.000125	0.000743	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.000125	0.000742	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.000125	0.000742	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000123	0.000732	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00012	0.000716	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000117	0.000696	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000116	0.000692	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000116	0.000692	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.000116	0.000691	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000115	0.000686	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.000115	0.000682	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000114	0.000681	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000114	0.000675	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000113	0.000671	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000113	0.00067	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.000112	0.000667	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.000112	0.000667	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000111	0.000659	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—ADM—bipolar disorder	0.00011	0.000652	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000109	0.000651	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000109	0.000646	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—COMT—bipolar disorder	0.000107	0.000637	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—TSHB—bipolar disorder	0.000107	0.000636	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—TACR1—bipolar disorder	0.000107	0.000636	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR2A—bipolar disorder	0.000106	0.000632	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—MAOA—bipolar disorder	0.000106	0.000632	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR1A—bipolar disorder	0.000106	0.000631	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.000105	0.000627	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TAC1—bipolar disorder	0.000104	0.000621	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—HTR2A—bipolar disorder	0.000104	0.000618	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.000103	0.000614	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR2C—bipolar disorder	0.000102	0.000609	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—DRD1—bipolar disorder	0.000102	0.000609	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000102	0.000608	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.000102	0.000606	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000102	0.000604	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	9.97e-05	0.000593	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	9.97e-05	0.000593	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NTRK2—bipolar disorder	9.96e-05	0.000592	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—DRD3—bipolar disorder	9.92e-05	0.00059	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GSK3A—bipolar disorder	9.87e-05	0.000587	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	9.83e-05	0.000585	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—ADM—bipolar disorder	9.74e-05	0.000579	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	9.65e-05	0.000574	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—DRD4—bipolar disorder	9.63e-05	0.000573	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—TSHB—bipolar disorder	9.49e-05	0.000565	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—TACR1—bipolar disorder	9.49e-05	0.000565	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—DGKH—bipolar disorder	9.37e-05	0.000558	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	9.37e-05	0.000557	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—POMC—bipolar disorder	9.35e-05	0.000556	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	9.29e-05	0.000553	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—HTR2A—bipolar disorder	9.23e-05	0.000549	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ADCY2—bipolar disorder	9.06e-05	0.000539	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TCF7L2—bipolar disorder	9.03e-05	0.000537	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	8.98e-05	0.000534	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—DRD2—bipolar disorder	8.97e-05	0.000533	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR1A—bipolar disorder	8.85e-05	0.000526	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	8.73e-05	0.000519	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—TAC1—bipolar disorder	8.71e-05	0.000518	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—DRD5—bipolar disorder	8.57e-05	0.00051	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—DRD1—bipolar disorder	8.54e-05	0.000508	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR2C—bipolar disorder	8.54e-05	0.000508	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—DGKH—bipolar disorder	8.51e-05	0.000506	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—POMC—bipolar disorder	8.49e-05	0.000505	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—RGS4—bipolar disorder	8.41e-05	0.0005	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—DGKH—bipolar disorder	8.32e-05	0.000495	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—DRD3—bipolar disorder	8.27e-05	0.000492	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	8.26e-05	0.000491	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NTRK1—bipolar disorder	8.12e-05	0.000483	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	8.03e-05	0.000478	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—DRD4—bipolar disorder	8.03e-05	0.000478	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—S100B—bipolar disorder	7.89e-05	0.00047	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR1A—bipolar disorder	7.86e-05	0.000467	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—DRD5—bipolar disorder	7.78e-05	0.000463	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—TAC1—bipolar disorder	7.74e-05	0.00046	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	7.64e-05	0.000454	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RGS4—bipolar disorder	7.63e-05	0.000454	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—DRD5—bipolar disorder	7.61e-05	0.000453	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR2C—bipolar disorder	7.59e-05	0.000451	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—DRD1—bipolar disorder	7.59e-05	0.000451	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	7.59e-05	0.000451	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—DGKH—bipolar disorder	7.56e-05	0.00045	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—DRD2—bipolar disorder	7.48e-05	0.000445	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—RGS4—bipolar disorder	7.47e-05	0.000444	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—COMT—bipolar disorder	7.38e-05	0.000439	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—DRD3—bipolar disorder	7.35e-05	0.000437	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—MAOA—bipolar disorder	7.33e-05	0.000436	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	7.28e-05	0.000433	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	7.14e-05	0.000424	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—DRD4—bipolar disorder	7.14e-05	0.000424	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NRG1—bipolar disorder	6.97e-05	0.000414	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—DRD5—bipolar disorder	6.91e-05	0.000411	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	6.88e-05	0.000409	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RGS4—bipolar disorder	6.78e-05	0.000403	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ADCY2—bipolar disorder	6.72e-05	0.0004	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—DRD2—bipolar disorder	6.65e-05	0.000395	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TRPC3—bipolar disorder	6.5e-05	0.000386	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—IMPA2—bipolar disorder	6.32e-05	0.000376	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR2A—bipolar disorder	6.28e-05	0.000374	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADM—bipolar disorder	6.2e-05	0.000369	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	6.11e-05	0.000364	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PDE4B—bipolar disorder	6.04e-05	0.000359	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TSHB—bipolar disorder	6.04e-05	0.000359	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TACR1—bipolar disorder	6.04e-05	0.000359	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TRPC3—bipolar disorder	5.9e-05	0.000351	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TRPC3—bipolar disorder	5.77e-05	0.000343	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADM—bipolar disorder	5.63e-05	0.000335	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADM—bipolar disorder	5.5e-05	0.000327	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	5.5e-05	0.000327	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PDE4B—bipolar disorder	5.48e-05	0.000326	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TSHB—bipolar disorder	5.48e-05	0.000326	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TACR1—bipolar disorder	5.48e-05	0.000326	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKR1C4—bipolar disorder	5.46e-05	0.000325	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PDE4B—bipolar disorder	5.36e-05	0.000319	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TSHB—bipolar disorder	5.36e-05	0.000319	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TACR1—bipolar disorder	5.36e-05	0.000319	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR2A—bipolar disorder	5.24e-05	0.000312	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TRPC3—bipolar disorder	5.24e-05	0.000312	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GSK3B—bipolar disorder	5.06e-05	0.000301	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DGKH—bipolar disorder	5.03e-05	0.000299	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—POMC—bipolar disorder	5.02e-05	0.000298	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR1A—bipolar disorder	5e-05	0.000297	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADM—bipolar disorder	5e-05	0.000297	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—INS—bipolar disorder	4.99e-05	0.000297	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TAC1—bipolar disorder	4.92e-05	0.000293	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.88e-05	0.00029	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TACR1—bipolar disorder	4.87e-05	0.00029	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PDE4B—bipolar disorder	4.87e-05	0.00029	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TSHB—bipolar disorder	4.87e-05	0.00029	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKR1C4—bipolar disorder	4.85e-05	0.000289	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR2C—bipolar disorder	4.83e-05	0.000287	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—DRD1—bipolar disorder	4.83e-05	0.000287	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—POMC—bipolar disorder	4.77e-05	0.000284	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—DRD3—bipolar disorder	4.68e-05	0.000278	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR2A—bipolar disorder	4.66e-05	0.000277	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD5—bipolar disorder	4.6e-05	0.000274	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR1A—bipolar disorder	4.54e-05	0.00027	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—DRD4—bipolar disorder	4.54e-05	0.00027	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RGS4—bipolar disorder	4.51e-05	0.000268	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TAC1—bipolar disorder	4.47e-05	0.000266	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DGKH—bipolar disorder	4.47e-05	0.000266	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR1A—bipolar disorder	4.44e-05	0.000264	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—DRD1—bipolar disorder	4.38e-05	0.000261	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR2C—bipolar disorder	4.38e-05	0.000261	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TAC1—bipolar disorder	4.37e-05	0.00026	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—DRD1—bipolar disorder	4.29e-05	0.000255	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR2C—bipolar disorder	4.29e-05	0.000255	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADCY2—bipolar disorder	4.27e-05	0.000254	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—IMPA1—bipolar disorder	4.27e-05	0.000254	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—DRD3—bipolar disorder	4.25e-05	0.000253	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—DRD2—bipolar disorder	4.23e-05	0.000252	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—POMC—bipolar disorder	4.19e-05	0.000249	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—DRD3—bipolar disorder	4.15e-05	0.000247	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—DRD4—bipolar disorder	4.12e-05	0.000245	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD5—bipolar disorder	4.08e-05	0.000243	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR1A—bipolar disorder	4.03e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—DRD4—bipolar disorder	4.03e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RGS4—bipolar disorder	4.01e-05	0.000238	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TAC1—bipolar disorder	3.97e-05	0.000236	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2C—bipolar disorder	3.89e-05	0.000232	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—DRD1—bipolar disorder	3.89e-05	0.000232	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADCY2—bipolar disorder	3.88e-05	0.000231	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—DRD2—bipolar disorder	3.84e-05	0.000228	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADCY2—bipolar disorder	3.8e-05	0.000226	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—DRD3—bipolar disorder	3.77e-05	0.000224	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—DRD2—bipolar disorder	3.76e-05	0.000223	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—POMC—bipolar disorder	3.72e-05	0.000221	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—DRD4—bipolar disorder	3.66e-05	0.000218	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	3.63e-05	0.000216	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	3.51e-05	0.000209	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TRPC3—bipolar disorder	3.48e-05	0.000207	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADCY2—bipolar disorder	3.45e-05	0.000205	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—DRD2—bipolar disorder	3.41e-05	0.000203	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADM—bipolar disorder	3.32e-05	0.000198	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TSHB—bipolar disorder	3.24e-05	0.000193	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDE4B—bipolar disorder	3.24e-05	0.000193	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TACR1—bipolar disorder	3.24e-05	0.000193	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NR1D1—bipolar disorder	3.16e-05	0.000188	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TRPC3—bipolar disorder	3.1e-05	0.000184	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCAN—bipolar disorder	3.02e-05	0.00018	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR2A—bipolar disorder	2.96e-05	0.000176	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	2.96e-05	0.000176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADM—bipolar disorder	2.95e-05	0.000176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TSHB—bipolar disorder	2.88e-05	0.000171	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDE4B—bipolar disorder	2.88e-05	0.000171	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TACR1—bipolar disorder	2.88e-05	0.000171	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR2A—bipolar disorder	2.69e-05	0.00016	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR1A—bipolar disorder	2.68e-05	0.00016	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TAC1—bipolar disorder	2.64e-05	0.000157	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	2.63e-05	0.000156	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD1—bipolar disorder	2.59e-05	0.000154	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2C—bipolar disorder	2.59e-05	0.000154	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK2—bipolar disorder	2.52e-05	0.00015	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD3—bipolar disorder	2.51e-05	0.000149	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GSK3A—bipolar disorder	2.5e-05	0.000149	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD4—bipolar disorder	2.44e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	2.39e-05	0.000142	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	2.38e-05	0.000142	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—bipolar disorder	2.37e-05	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	2.35e-05	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	2.3e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	2.3e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADCY2—bipolar disorder	2.29e-05	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TCF7L2—bipolar disorder	2.28e-05	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	2.27e-05	0.000135	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	2.24e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	2.23e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	2.22e-05	0.000132	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	2.16e-05	0.000129	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	2.15e-05	0.000128	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.14e-05	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	2.1e-05	0.000125	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TSHB—bipolar disorder	2.08e-05	0.000124	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TPH2—bipolar disorder	2.08e-05	0.000124	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CACNB2—bipolar disorder	2.08e-05	0.000124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	2.05e-05	0.000122	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DPYD—bipolar disorder	2.05e-05	0.000122	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	2.04e-05	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	2.03e-05	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	2.02e-05	0.00012	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—S100B—bipolar disorder	2e-05	0.000119	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	1.91e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.91e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.86e-05	0.00011	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	1.82e-05	0.000109	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—S100B—bipolar disorder	1.77e-05	0.000105	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	1.76e-05	0.000105	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.67e-05	9.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	1.59e-05	9.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	1.57e-05	9.31e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.47e-05	8.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	1.41e-05	8.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	1.28e-05	7.61e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—bipolar disorder	1.27e-05	7.55e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—COMT—bipolar disorder	1.26e-05	7.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—INS—bipolar disorder	1.26e-05	7.51e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MAOA—bipolar disorder	1.25e-05	7.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	1.14e-05	6.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—bipolar disorder	1.13e-05	6.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—INS—bipolar disorder	1.12e-05	6.67e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.02e-05	6.07e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—bipolar disorder	8.16e-06	4.85e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—INS—bipolar disorder	8.12e-06	4.83e-05	CbGpPWpGaD
